Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.7
38.01%
40%
—
16x
Every year
—
5 Years
Score5.7
Net Growth38.01%
Net Trend40%
Net Income Consistency—
Rev Growth16x
Rev TrendEvery year
Revenue Consistency—
Legend Biotech Corp fundamental performance
Between 2020 and 2025, revenue grew from $ 75M to $ 1.02B and net income went from -$ 266M to -$ 296M. Revenue increased in every one of those 5 years; net income in 2.
Legend Biotech Corp currently holds a 5-year HDB Score of 5.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 20.65 | — |
1 Year2025-08-12 | $ 36.99 | -44.17% |
5 Years2021-08-12 | $ 40.11 | -48.52% |
All Time2020-06-05 | $ 37.00 | -44.19% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-06-05 |
|---|---|---|---|---|
| Price | $ 20.65 | $ 36.99 | $ 40.11 | $ 37.00 |
| Return | — | -44.17% | -48.52% | -44.19% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1.13B | -$ 250M | $ 834M |
| 2025 | $ 1.02B | -$ 296M | $ 948M |
| 2024 | $ 627M | -$ 177M | $ 1.12B |
| 2023 | $ 285M | -$ 518M | $ 1.30B |
| 2022 | $ 117M | -$ 446M | $ 1.02B |
| 2021 | $ 68M | -$ 403M | $ 882M |
| IPO2020 | $ 75M | -$ 266M | $ 506M |
Explore beyond LEGN
You're looking at Legend Biotech Corp. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
